Milestone Pharmaceuticals
MIST
MIST
31 hedge funds and large institutions have $111M invested in Milestone Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
23.06% more ownership
Funds ownership: 39.6% → 62.66% (+23%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $523K
Holders
31
Holding in Top 10
1
Calls
–
Puts
$523K
Top Buyers
| 1 | +$17.3M | |
| 2 | +$12.5M | |
| 3 | +$4.84M | |
| 4 |
O
OrbiMed
New York
|
+$2.77M |
| 5 |
Millennium Management
New York
|
+$2.21M |
Top Sellers
| 1 | -$642K | |
| 2 | -$455K | |
| 3 | -$125K | |
| 4 |
SAMH
Shanda Asset Management Holdings
Tortola,,
British Virgin Islands
|
-$98K |
| 5 |
Two Sigma Advisers
New York
|
-$79K |